NewsCBD’s High St March Takes All Before It

CBD’s High St March Takes All Before It

-

HIGH END British department store Selfridges has listed the CBD range of a new UK start-up which has also been boosted by a 847,000 Euro investment.

London-based Grass & Co was launched last year by experienced entrepreneur Ben Grass, and has quickly made rapid market strides.

Its tie-up with Selfridges will see the leading department store stock a range of its CBD products in its London and Manchester outlets and on its website selfridges.com.

The company has also closed an €847,000 seed financing round backed by a number of experienced angel investors.

Toby Gordon-Smith, CEO, Grass & Co said its is ‘committed to producing a quality, ethically sourced CBD product free from pesticides and herbicides that consumers can trust’.

Selfridges currently stock Kiki Health CBD products and its latest CBD deal will see it carry Grass & Co’s Ease and Calm ranges, which include body oils and muscle balms.

Selfridges is the latest major high street brand to succumb to the CBD juggernaut – with over one million daily users in the U.K. the market is set to be worth over £1bn within a few years.

World-renowned London brand Harrods now stock a range supplied by Dragonfly Biosciences, whilst Tesco recently launched a range supplied by Vitality CBD.

Both UK health food shop Holland & Barrett and health and wellness,  and pharmacy chain Boots also stock and sell CBD products.

Peter
Peter
Peter McCusker is an experienced news and business editor, who believes it’s time to fully embrace the multiple, proven, medical benefits of the cannabis plant.

Latest news

Grow Group, Kanabo, MGC Pharma & Celadon Pharma All Report Growing Revenues, But Continue To Post Losses

AMID the economic chaos that dominated the headlines over the past week, nearly half-a-dozen UK-based or UK-listed cannabis companies...

MGC Pharma Announces Appointment Of UK Advisor And New COO/Deputy CEO

MGC Pharmaceuticals Ltd ('MGC Pharma' or 'the Company') a European based bio-pharma company specialising in the production and development...

Sanity Group’s Record Funding Round Led By BAT Could Bring More Big-Tobacco Capital To Cannabis, But Concerns Remain Over Conflicts Of Interest

LAST week Berlin-based cannabis operator Sanity Group closed Europe’s largest ever cannabis investment round worth €37.6m, bringing its total...

European Cannabis Stocks Review: £22m Wiped From LSE-Listed Cannabis Stocks Amid Market Chaos

FOLLOWING a few weeks of relative positivity for many of the stocks listed on the London Stock Exchange (LSE),...

German SPD Representatives Confident A Solution To International Legal Hurdles Will Be Found

EARLIER this month news broke that recent analysis conducted by the Bundestag's scientific service suggested the creation of a...

‘Collaborative Vertical Integration Has To Be The Way Forward For the European Cannabis Industry’

BACK in 2019 at a US industry conference while discussing cannabis business models a top executive from JP...

Must read

You might also likeRELATED
Recommended to you